ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,285.22
0.29%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE
  6. Novartis AG (NVS)

  7. Novartis AG (NVS) 뉴스

NVS Novartis AG

97.44
-1.62 (-1.64%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Novartis AG NVS NYSE 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-1.62 -1.64% 97.44 09:00:00
개장가 저가 고가 종가 전일 종가
97.76 97.44 98.22 97.44 99.06
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202420:25IHMARKETNEWSApple Loses Market Share in China, GM Surges in Pre-Market..
16/04/202403:00PRNUSNew Novartis Fabhalta® (iptacopan) data show clinically..
11/04/202420:00GLOBEArvinas Enters into a Transaction with Novartis, including a..
10/04/202420:13IHMARKETNEWSDelta Generates US$37 Million Profit in Q1, Google and Intel..
07/04/202405:16PRNUSNew Novartis data show early addition of twice-yearly*..
16/02/202406:15EDGAR2Form S-8 POS - Securities to be offered to employees in..
07/02/202406:52EDGAR2Form SC TO-C - Written communication relating to an issuer..
06/02/202420:14IHMARKETNEWSBoeing Faces Strike Threat, Palantir Up 18% After Recording..
06/02/202407:06EDGAR2Form SC TO-C - Written communication relating to an issuer..
03/02/202404:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/01/202421:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/01/202421:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/01/202421:42EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
31/01/202421:38EDGAR2Form 20-F - Annual and transition report of foreign private..
31/01/202420:28IHMARKETNEWSWalmart’s Stock Split, Elon Musk’s Billion-Dollar Package..
22/01/202415:59DJNSandoz to Acquire Cimerli Business from Coherus for $170..
12/01/202420:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
12/01/202403:02DJNCytokinetics Shares Slide as Novartis Reportedly Shies Away..
09/01/202403:43DJNCytokinetics Shares Jump 16% After WSJ Report of Novartis..
09/01/202400:41DJNNovartis on Track for Record High Close -- Data Talk
08/01/202420:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/01/202416:01DJNNovartis's Scemblix Drug Meets Main Goals in Late-Stage..
06/01/202400:15DJNNovartis to Make Pluvicto Radioligand Therapy at..
02/01/202421:46DJNVoyager Therapeutics Shares Leap Premarket on Novartis..
11/12/202320:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202316:02DJNNovartis Drug Meets Primary Goal in Late-Stage Study for..
11/12/202309:39PRNUSNovartis presents new 48-week results from Phase III..
06/12/202319:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
06/12/202314:18PRNUSNovartis receives FDA approval for Fabhalta® (iptacopan),..
05/12/202320:25IHMARKETNEWSMoody’s Reassesses China, GitLab Exceeds Estimates, Twilio..
29/11/202320:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
29/11/202305:08DJNFDA Looking Into All Approved CAR T Therapies on Risk of..
28/11/202320:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202316:12DJNNovartis Raises Mid-Term Sales Growth Targets
13/11/202323:16DJNLegend Biotech Subsidiary in License Agreement With Novartis
01/11/202321:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
01/11/202315:43DJNNovartis Skin Treatment Drug Cosentyx Gets US FDA Approval
30/10/202319:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202316:07DJNNovartis to Seek US Accelerated Approval of Atrasentan After..
27/10/202314:45DJNNovartis Says FDA Deems Pluvicto Shortage Resolved, Supply..
24/10/202320:22IHMARKETNEWSTuesday’s Wall Street Highlights: Coinbase, Intel, Redfin,..
24/10/202319:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202316:32DJNNovartis Raises Earnings Guidance Again After Key Drugs..
24/10/202314:48DJNNovartis Raises Earnings Guidance After Key Drugs Boost..
07/10/202306:11DJNNovartis Gets FDA Approval IV Formulation of Cosentyx
04/10/202319:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202318:17DJNNovartis Spinoff Sandoz Group Valued at $11.2 Billion in..
02/10/202319:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202315:10DJNNovartis Says Kidney Drug Phase 3 Trial Reaches Positive..
26/09/202315:03DJNNovartis's Sandoz to Commercialize Multiple Sclerosis..

최근 히스토리

NYSE
NVS
Novartis
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유